Article Sidebar

PDF
Issue: Vol. 561 No. 3 (2026)
Section: Các bài báo
DOI: 10.51298/vmj.v561i3.18460
Date Published: 11/08/2026
Views 38
Downloads 30
How to Cite
Nguyễn, T. Đ., Văn, T. T., & Nguyễn, T. A. (2026). THE CORRELATION BETWEEN THE TRIGLYCERIDEE-GLUCOSE INDEX (TYG INDEX) AND CLINICAL FACTORS IN PSORIASIS PATIENTS. Vietnam Medical Journal, 561(3). https://doi.org/10.51298/vmj.v561i3.18460

THE CORRELATION BETWEEN THE TRIGLYCERIDEE-GLUCOSE INDEX (TYG INDEX) AND CLINICAL FACTORS IN PSORIASIS PATIENTS.

Thành Đạt Nguyễn1,2, Thế Trung Văn1, , Tâm Anh Nguyễn1
1 Đại học Quốc Gia Thành phố Hồ Chí Minh
2 Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Abstract

Objective: This study was conducted to determine the cut-off value, sensitivity and specificity of the Triglyceride-glucose Index (TyG Index) in screening for metabolic syndrome (MetS) among psoriasis patients.


Methods: A cross – sectional study was conducted at Ho Chi Minh City Hospital of Dermato-Venereology with 160 participants from March 2024 to September 2024. Data collected included clinical characteristics, laboratory findings and TyG index value. The cut-off value of TyG Index was determined using ROC curve analysis.


Result: The prevalence of metabolic syndrome among psoriasis patients was 68% with a higher rate observed in patients with severe psoriasis compared to those with mild to moderate disease. The optimal cut-off value of the TyG Index for screening MetS was 8.77 with sensitivity of 81.94% and a specificity of 86.36%.


Conclusion: The TyG index is an effective and practical tool for screening MetS psoriasis patients. Its application can facilitate early detection and improve the management of related comorbidities.

Keywords

TyG Index, psoriasis, metabolic syndrome

Article Details

References

1. Boehncke WH, Schön MP. Psoriasis. Lancet (London, England). Sep 5 2015;386(9997):983-94. doi:10.1016/s0140-6736(14)61909-7
2. Hao Y, Zhu YJ, Zou S, et al. Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front Immunol. 2021;12:711060. doi:10.3389/fimmu.2021.711060
3. Teklu M, Zhou W, Kapoor P, et al. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study. J Am Acad Dermatol. May 2021;84(5):1329-1338. doi:10.1016/j.jaad.2020.12.044
4. Albareda M, Ravella A, Castelló M, et al. Metabolic syndrome and its components in patients with psoriasis. SpringerPlus. 2014/10/17 2014;3(1):612. doi:10.1186/2193-1801-3-612
5. O’Hagan R, Gonzalez-Cantero A, Patel N, et al. Association of the Triglyceridee glucose index with insulin resistance and subclinical atherosclerosis in psoriasis: An observational cohort study. J Am Acad Dermatol. May 2023;88(5):1131-1134. doi:10.1016/j.jaad.2022.08.027
6. Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, et al. The accuracy of Triglyceridee-glucose (TyG) index for the screening of metabolic syndrome in adults: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. Dec 2022;32(12):2677-2688. doi:10.1016/j.numecd.2022.07.024
7. Son DH, Lee HS, Lee YJ, et al. Comparison of Triglyceridee-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. Mar 2022;32(3):596-604. doi:10.1016/j.numecd.2021.11.017